Cavitation Technologies, Inc. (CVAT)
2025-03-31 | 2024-12-31 | |||
|---|---|---|---|---|
| Revenue | 122 | 76 | ||
| Cost of revenue | 25 | 13 | ||
| Gross profit | 97 | 63 | ||
| Research and development expenses | 42 | 16 | ||
| General and administrative expenses | 283 | 346 | ||
| Total operating expenses | 325 | 362 | ||
| Income (loss) from operations | -228 | -299 | ||
| Interest expense | 2 | 2 | ||
| Gain on patent assignment | - | 880 | ||
| Net income (loss) | -230 | 579 | ||
| Basic eps | - | - | ||
| Diluted eps | - | - | ||
| Basic average shares | 286,467,487 | 284,289,740 | ||
| Diluted average shares | 286,467,487 | 284,289,740 | ||